Nipro Corporation (TYO:8086)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Medical Related	530.93B	512.01B	459.33B	426.07B	379.85B
Medical Related Growth	3.69%	11.47%	7.81%	12.17%	7.37%
Unallocated Adjustment	-81.20B	-83.78B	-71.40B	-38.26B	-35.18B
Pharmaceutical related	141.70B	142.96B	129.61B	95.23B	94.98B
Pharmaceutical related Growth	-0.88%	10.30%	36.10%	0.27%	9.11%
Others	7.10B	7.29B	4.96B	4.44B	2.66B
Others Growth	-2.73%	46.97%	11.68%	67.38%	13.12%
Pharma Packaging	62.01B	66.10B	64.29B	57.72B	52.49B
Pharma Packaging Growth	-6.18%	2.82%	11.38%	9.95%	17.15%
Total	660.54B	644.59B	586.78B	545.20B	494.79B
Total Growth	2.47%	9.85%	7.63%	10.19%	8.61%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan	314.47B	304.60B	290.18B	280.09B
Japan Growth	3.24%	4.97%	3.60%	3.53%
U.S.A	130.15B	108.02B	98.09B	78.24B
U.S.A Growth	20.49%	10.12%	25.37%	9.32%
Europe	92.63B	77.20B	68.29B	60.38B
Europe Growth	19.99%	13.05%	13.11%	15.74%
Asia	107.33B	96.96B	88.64B	76.08B
Asia Growth	10.70%	9.39%	16.51%	24.15%
Total	644.58B	586.78B	545.20B	494.79B
Total Growth	9.85%	7.63%	10.19%	8.61%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 23, 2026

Data Sources Report a data error